DS
CRBP icon

David Shaw’s Corbus Pharmaceuticals CRBP Stock Holding History

David Shaw’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,474
Closed -$249K – 4919
2026
Q1 		$249K Sell
26,474
-2,320
-8% -$19.5K ﹤0.01% 4131
2025
Q4 		$234K Buy
28,794
+18,167
+171% +$224K ﹤0.01% 4268
2025
Q3 		$134K Buy
+10,627
New +$101K ﹤0.01% 4331
2022
Q2 		– Sell
-32,764
Closed -$522K – 5391
2022
Q1 		$522K Buy
32,764
+5,447
+20% +$72.2K ﹤0.01% 4346
2021
Q4 		$505K Buy
27,317
+4,693
+21% +$127K ﹤0.01% 4398
2021
Q3 		$692K Sell
22,624
-1,224
-5% -$48.3K ﹤0.01% 3875
2021
Q2 		$1.31M Buy
23,848
+5,805
+32% +$322K ﹤0.01% 3326
2021
Q1 		$1.07M Sell
18,043
-51,095
-74% -$3.36M ﹤0.01% 3061
2020
Q4 		$2.59M Sell
69,138
-8,045
-10% -$301K ﹤0.01% 2382
2020
Q3 		$4.17M Buy
77,183
+7,905
+11% +$1.43M ﹤0.01% 1828
2020
Q2 		$17.4M Buy
69,278
+27,569
+66% +$5.57M 0.02% 858
2020
Q1 		$6.56M Buy
41,709
+19,204
+85% +$3.25M 0.01% 1253
2019
Q4 		$3.69M Sell
22,505
-2,132
-9% -$315K ﹤0.01% 1985
2019
Q3 		$3.6M Sell
24,637
-7,067
-22% -$1.23M ﹤0.01% 1890
2019
Q2 		$6.59M Sell
31,704
-7,448
-19% -$1.59M 0.01% 1401
2019
Q1 		$8.16M Buy
39,152
+21,315
+119% +$4.7M 0.01% 1241
2018
Q4 		$3.13M Buy
+17,837
New +$3.56M ﹤0.01% 1821
2018
Q1 		– Sell
-396
Closed -$84K – 3532
2017
Q4 		$84K Sell
396
-25
-6% -$5.35K ﹤0.01% 3505
2017
Q3 		$90K Buy
+421
New +$82.4K ﹤0.01% 3375

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

David Shaw's CRBP Position: Q2 2026 in Review

David Shaw sold out of Corbus Pharmaceuticals (CRBP) in Q2 2026, closing a stake of 26,474 shares — an estimated $249K sold.

David Shaw first reported a position in CRBP in Q3 2017 and held it in 19 quarters. The position peaked at $17.4M in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • David Shaw reported no remaining Corbus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 26,474 Corbus Pharmaceuticals shares in Q2 2026, an estimated $249K.
  • David Shaw first reported a position in Corbus Pharmaceuticals in Q3 2017 and held it in 19 quarters.
  • David Shaw's Corbus Pharmaceuticals position peaked at $17.4M in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.